110 A Pilot Dose Finding Study of Pioglitazone in Children with ASD
L. Capano J. A. Brian D. Mankad S. Smile L. Genore R. Hastie Adams A. Iaboni D. Odrobina A. Dupuis E. Anagnostou

111 Changes in Sleep Habits during Drug Treatment of ASD
R. K. Abramson A. V. Hall C. A. Stuck S. Ravan J. Charles J. Williams L. DeVane

112 Effectiveness of Propranolol for Treating Anxiety and Aggression in Children and Adolescents with Autism Spectrum Disorder
I. K. Sagar-Ouriaghli K. Lievesley J. Tarver F. Fiori P. J. Santosh

113 Immune Response to Pregnenolone Treatment in Adults with Autism Spectrum Disorder – Preliminary Analysis from an Open-Label Study
L. K. Fung J. Siebert A. Y. Hardan

114 Improvement of Receptive Language but Behavioral Worsening with Combined Donepezil and Choline Treatment
L. V. Gabis R. Ben-Hur Chayu D. Ben Shalom

115 Metformin for Medication-Associated Weight Gain in Youth with Autism Spectrum Disorder
L. K. Wink K. C. Dominick E. Pedapati E. Fox C. Buck R. Adams L. McClellan C. A. Erickson

116 Microbiota Transfer Improves Gastrointestinal and Autism Symptoms: An OPEN Label Study
D. W. Kang J. B. Adams A. C. Gregory T. Borody L. Chittick A. Fasano A. Khoruts E. Geis J. Maldonado S. McDonough-Means E. Pollard S. Roux M. J. Sadowsky K. Schwarzberg Lipson M. B. Sullivan J. G. Caporaso R. Krajmalnik-Brown

117 Multi-Site Randomized Controlled Trial of Fluoxetine in Children and Adolescents with Autism (FAB)
A. Mouti M. Kohn D. Reddihough C. Marraffa P. Hazell J. Wray K. Lee P. J. Santosh D. Dossetor N. Silove A. J. Whitehouse J. Granich M. O'Sullivan F. Orsini P. Lockhart

118 Open Label Clinical Trial of Sulforaphane in School-Aged Children with Autism with Metabolomic Biomarkers
S. Bent T. Warren F. Widjaja K. Dang J. W. Fahey J. Kinchen J. Buckthal B. S. Cornblatt R. Hendren

119 Psychopharmacologic Intervention for Adults with Autism Spectrum Disorder: A Systematic Literature Review
L. Taylor

120 Systematic Screening of Pharmacological Compounds in Human Pluripotent Stem Cells-Derived Neurons to Identify Patient-Oriented Treatment for Autism: A Proof of Concept
H. Darville A. Poulet F. Amsellem L. Chatrousse J. Pernelle C. Boissart T. Bourgeron M. Peschanski R. Delorme A. Benchoua

121 The Effects of Four Weeks of Intranasal Oxytocin on Social Responsiveness and Repetitive and Restricted Behaviors in Autism Spectrum Disorders: A Randomized Controlled Trial
S. Bernaerts C. Dillen J. Steyaert K. Alaerts

122 The Effects of Oxyotcin on Socially Rewarded Learning in Autism Spectrum Disorder
A. T. Wang S. Soffes J. Zweifach L. Soorya J. D. Buxbaum A. Kolevzon J. A. Bartz

123 Trends in the Use of Psychotropic Medication for Children with Autism Spectrum Disorders on Kentucky Medicaid
W. D. Lohr Y. Feygin G. C. Liu M. J. Smith M. D. Stevenson D. W. Davis P. G. Williams C. Woods J. Myers